Skip to main content
Equibles

Donal O’Connor

Chairman

Theravance Biopharma, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Donal O’Connor

Donal O’Connor is recorded as Chairman at Theravance Biopharma, Inc.. Theravance Biopharma, Inc. reported in an 8-K filed September 23, 2026 that Donal O’Connor resigned as Board of Directors, effective September 23, 2026.

“at the Effective Time, each of Rick E Winningham, Laurie Smaldone Alsup, Susannah Gray, Dean J. Mitchell, Donal O’Connor and Deepa R. Pakianathan resigned from the Company’s Board of Directors”
Theravance Biopharma, Inc. Form 8-K, filed September 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Theravance Biopharma, Inc.

    Chairman

    Proxy statement

    Current

    Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Theravance Biopharma, Inc.

Current role

Chairman

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.